Molecular and functional interactions of alpha-synuclein with Rab3a.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
09 2022
Historique:
received: 15 03 2022
revised: 01 07 2022
accepted: 04 07 2022
pubmed: 10 7 2022
medline: 30 9 2022
entrez: 9 7 2022
Statut: ppublish

Résumé

Alpha-synuclein (a-Syn) is a presynaptic protein, the misfolding of which is associated with Parkinson's disease. Rab GTPases are small guanine nucleotide binding proteins that play key roles in vesicle trafficking and have been associated with a-Syn function and dysfunction. a-Syn is enriched on synaptic vesicles, where it has been reported to interact with GTP-bound Rab3a, a master regulator of synaptic vesicle trafficking. a-Syn is known to bind weakly to Rab8a in solution via a positively charged patch, but the physiological implications of such interactions have not been explored. Here, we investigate direct interactions between a-Syn and Rab3a in solution and on lipid membranes using NMR spectroscopy. We find that the C terminus of a-Syn interacts with Rab3a in a manner similar to its previously reported interaction with Rab8a. While weak in solution, we demonstrate that this interaction becomes stronger when the proteins are bound to a membrane surface. The Rab3a binding site for a-Syn is similar to the surface that contacts the Rab3a effector rabphilin-3A, which modulates the enzymatic activity of Rab3a. Accordingly, we show that a-Syn inhibits GTP hydrolysis by Rab3a and that inhibition is more potent on the membrane surface, suggesting that their interaction may be functionally relevant. Finally, we show that phosphorylation of a-Syn residue Ser 129, a modification associated with Parkinson's disease pathology, enhances its interactions with Rab3a and increases its ability to inhibit Rab3a GTP hydrolysis. These results represent the first observation of a functional role for synuclein-Rab interactions and for a-Syn Ser 129 phosphorylation.

Identifiants

pubmed: 35809645
pii: S0021-9258(22)00681-0
doi: 10.1016/j.jbc.2022.102239
pmc: PMC9396396
pii:
doi:

Substances chimiques

Lipids 0
SNCA protein, human 0
alpha-Synuclein 0
Guanosine Triphosphate 86-01-1
rab3A GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

102239

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM136686
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG019391
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Guohua Lv (G)

Department of Biochemistry, Weill Cornell Medical College, New York, New York, USA.

Myung Soo Ko (MS)

Department of Biochemistry, Weill Cornell Medical College, New York, New York, USA.

Tapojyoti Das (T)

Department of Biochemistry, Weill Cornell Medical College, New York, New York, USA.

David Eliezer (D)

Department of Biochemistry, Weill Cornell Medical College, New York, New York, USA. Electronic address: dae2005@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH